Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients.
NLR
cytokines
myosteatosis
sarcopenia
systemic inflammation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
09 May 2022
09 May 2022
Historique:
received:
01
03
2022
revised:
29
04
2022
accepted:
05
05
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
15
5
2022
Statut:
epublish
Résumé
Cancer patients commonly present sarcopenia, myosteatosis, and systemic inflammation, which are risk factors of poor survival. In this study, sarcopenia and myosteatosis were defined from preoperative body computed tomography scans of 222 colorectal cancer (CRC) patients and analyzed in relation to tumor and patient characteristics, markers of systemic inflammation (modified Glasgow prognostic score (mGPS), neutrophil−lymphocyte ratio (NLR), serum levels of C-reactive protein (CRP), albumin, and 13 cytokines, and survival. Of the systemic inflammation markers, sarcopenia and/or myosteatosis associated with elevated NLR (p = 0.005) and low albumin levels (≤35 g/L) (p = 0.018), but not with mGPS or serum cytokine levels. In addition, myosteatosis was associated with a proximal tumor location (p = 0.039), serrated tumor subtype (p < 0.001), and severe comorbidities (p = 0.004). Multivariable analyses revealed that severe comorbidities and serrated histology were independent predictors of myosteatosis, and older age and elevated NLR were independent indicators of sarcopenia. Myosteatosis associated with shorter overall survival in univariable analysis (HR 1.959, 95% CI 1.24−3.10, p = 0.004) but not in multivariable analysis (p = 0.075). We conclude that sarcopenia and myosteatosis were associated with inflammatory marker NLR, but not with mGPS. Moreover, patients with serrated CRC may have an increased risk of myosteatosis. Myosteatosis or sarcopenia were not independent predictors of patient survival.
Identifiants
pubmed: 35566781
pii: jcm11092656
doi: 10.3390/jcm11092656
pmc: PMC9104763
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nat Cancer. 2021 Mar;2(3):271-283
pubmed: 33870211
Br J Cancer. 2012 Sep 4;107(6):931-6
pubmed: 22871883
Clin Nutr. 2018 Aug;37(4):1279-1285
pubmed: 28566220
J Pathol. 2005 Nov;207(3):285-94
pubmed: 16177963
Surg Today. 2018 Feb;48(2):151-157
pubmed: 28699003
Histopathology. 2007 Jan;50(1):131-50
pubmed: 17204027
Cancers (Basel). 2020 Jul 21;12(7):
pubmed: 32708140
Best Pract Res Clin Rheumatol. 2017 Apr;31(2):218-242
pubmed: 29224698
Crit Rev Oncol Hematol. 2013 Oct;88(1):218-30
pubmed: 23602134
Br J Cancer. 2012 Nov 6;107(10):1729-36
pubmed: 23059742
Cancers (Basel). 2019 Sep 04;11(9):
pubmed: 31487957
Cancer. 2018 Jul 15;124(14):3008-3015
pubmed: 29797673
J Oncol. 2021 Jun 18;2021:6687291
pubmed: 34239564
Crit Rev Oncol Hematol. 2020 Jan;145:102839
pubmed: 31877534
Ann Surg. 2014 Aug;260(2):287-92
pubmed: 24096764
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S127-S131
pubmed: 28017281
Clin Nutr. 2017 Feb;36(1):49-64
pubmed: 27642056
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
World J Gastroenterol. 2019 Aug 21;25(31):4383-4404
pubmed: 31496619
Acta Oncol. 2020 Jul;59(7):799-808
pubmed: 32228271
Ann Surg. 2016 Feb;263(2):326-36
pubmed: 25575264
Eur J Surg Oncol. 2020 Sep;46(9):1656-1662
pubmed: 32224072
Eur J Endocrinol. 2015 Aug;173(2):217-25
pubmed: 25953830
J Clin Gastroenterol. 2006 Aug;40(7):592-5
pubmed: 16917399
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):111-122
pubmed: 30460764
Int J Colorectal Dis. 2007 Aug;22(8):881-6
pubmed: 17245566
Aging Clin Exp Res. 2021 Nov;33(11):2929-2939
pubmed: 33566325
Am J Clin Nutr. 2019 Mar 1;109(3):615-625
pubmed: 30850836
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):956-961
pubmed: 31523937
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):53-59
pubmed: 28849630
Ann Surg. 2016 Feb;263(2):320-5
pubmed: 25643288
J Clin Oncol. 2013 Apr 20;31(12):1539-47
pubmed: 23530101
Crit Rev Oncol Hematol. 2017 Aug;116:134-146
pubmed: 28693795
World J Clin Cases. 2020 Apr 6;8(7):1188-1202
pubmed: 32337193
Br J Cancer. 2005 Aug 22;93(4):387-91
pubmed: 16106245
Virchows Arch. 2014 Jun;464(6):637-43
pubmed: 24722974
Cell Metab. 2013 May 7;17(5):695-708
pubmed: 23663738
J Pathol. 2001 Mar;193(3):286-94
pubmed: 11241406
Int J Cancer. 2012 Aug 15;131(4):E463-74
pubmed: 21918979
Clin Nutr. 2016 Aug;35(4):924-7
pubmed: 26205321
J Cachexia Sarcopenia Muscle. 2020 Oct;11(5):1270-1282
pubmed: 32483936
Ann Surg Oncol. 2015 Aug;22(8):2663-8
pubmed: 25564158
Br J Surg. 2003 Feb;90(2):215-9
pubmed: 12555298
Sci Rep. 2018 Jan 18;8(1):1126
pubmed: 29348549
Br J Surg. 2016 Apr;103(5):572-80
pubmed: 26994716
Dig Dis Sci. 2018 Jun;63(6):1620-1630
pubmed: 29549473
JAMA Oncol. 2017 Dec 1;3(12):e172319
pubmed: 28796857
Cancer Treat Rev. 2013 Aug;39(5):534-40
pubmed: 22995477
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):207-217
pubmed: 30920778
Clin Geriatr Med. 2017 Feb;33(1):17-26
pubmed: 27886695
Dis Colon Rectum. 2019 May;62(5):549-560
pubmed: 30789442
Eur J Surg Oncol. 2018 Sep;44(9):1354-1360
pubmed: 29914788
Front Endocrinol (Lausanne). 2016 Jun 20;7:69
pubmed: 27379021
Colorectal Dis. 2015 Nov;17(11):O256-64
pubmed: 26194849